Telehealth research and innovation for veterans with cancer (thrive) - the rapid uptake of telehealth since the coronavirus pandemic has highlighted not only the potential for telehealth to improve…
Active Project Grant Awarded Last action
- Award ID
- P50CA271358
- Recipient
-
New York University UEI M5SZJ6VHUHN8 Part of New York University
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,137,628
Award facts
- Assistance listing
- 93.310 Trans-NIH Research Support
- Completion date 85% complete
- Funding
-
- $8,009,025.00 Federal
- $1,128,603.00 Non-federal
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- Place of performance
- New York, NY 10016, USA
Award details come from USAspending.gov.
Description
Telehealth research and innovation for veterans with cancer (thrive) - the rapid uptake of telehealth since the coronavirus pandemic has highlighted not only the potential for telehealth to improve access and quality of care for some but also how telehealth can exacerbate the "digital divide," increasing disparities in care and highlighting the need to focus on health equity. Social, economic, environmental, and structural factors collectively known as social determinants of health (SDH) - account for 30-50% of the variance in health outcomes, far more than the 10-20% ascribed to health care. In order to achieve health equity, IT is crucial to target these SDH. We will particularly focus on race/ethnicity, poverty and rurality and how they affect use of telehealth, which we refer to as social determinants of telehealth (sdth). The veterans health administration (VA) is the largest integrated health care system in the US, providing care to 9 million patients across 171 medical centers and 1,112 outpatient sites. VA provides a unique opportunity to examine how sdth affect use of telehealth for cancer across a health care system with equal access and without focus on reimbursement. Therefore, the entire VA system will serve as our clinical practice network for this center. All three thrive PI's are experts in implementation science and will use the nimhd health disparities research framework and the consolidated framework for implementation research to guide our understanding of telehealth care delivery for patients with cancer and to explore and understand disparities. We propose a center called telehealth research and innovation for veterans with cancer (thrive), whose overarching aim is two-fold: 1) to understand how sdth impact the delivery of telehealth for cancer and 2) to develop methods to address sdth and thereby improve access and quality of cancer care for all patients. Thrive will focus on four highly important and prevalent cancers within VA: lung, colon, prostate, and breast. Our findings will be extremely valuable in understanding how telehealth implementation affects the quality of cancer care for the entire population and how VA and other US health systems can leverage telehealth to improve cancer outcomes and health equity. Our specific aims for this center are: (1) efficiently manage all components of thrive, including coordination, communication, fiscal management, recruitment and dissemination (administrative core); (2) identify the impact of sdth on disparities in telehealth use for cancer care and on overall quality of care and to develop and test implementation strategies to mitigate disparities (research and methods core); (3) create a high functioning learning network to facilitate research on telehealth for cancer (clinical practice network); (4) conduct a trial assessing the impact of a comprehensive, multilevel virtual oncology program on promoting engagement with telehealth and reducing sdth-related care disparities (pragmatic trial); and (5) train the next generation of oncology researchers in virtual care and health equity.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $165,120 | $0 | |
| Amendment | $216,486 | $0 | |
| Amendment | $1,072,319 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $1,033,571 | $0 | |
| Amendment | -$1,033,571 | $0 | |
| Amendment | $1,033,571 | $0 | |
| Amendment | $1,033,571 | $0 | |
| Amendment | $1,102,149 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $1,128,603 | $0 | |
| Amendment | $1,128,603 | $1,128,603 | |
| Original award | $1,128,603 | $0 |
Show all 15
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Institute For Medical Research Inc. | $168,581 | |
| Institute For Medical Research Inc. | $469,117 | |
| Institute For Medical Research Inc. | $16,668 |
Quick answers
Who received award P50CA271358?
P50CA271358 was awarded to New York University by National Cancer Institute (National Institutes of Health) on August 15, 2022.
How much is award P50CA271358 worth?
$9,137,628 has been obligated on P50CA271358: $8,009,025 in federal funding and $1,128,603 in non-federal funding.
Which agency awarded P50CA271358?
National Cancer Institute (National Institutes of Health) awarded P50CA271358, with funding from Office of the Director (National Institutes of Health).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award